CME Group Chairman and CEO Terrence Duffy filed a Form 144 notice of proposed sale on November 18, 2026, disclosing plans to sell 27,000 shares of CME Group common stock through Merrill.

Key Highlights

  • Proposed sale size: 27,000 shares of CME Group common stock with an aggregate market value of $8,338,917.93
  • Acquisition origin: The shares were acquired on March 15, 2025, through an executive compensation grant
  • Approximate sale date: November 18, 2026, to be executed through Merrill in Oak Brook, Illinois
  • Prior sales activity: Duffy sold 15,000 shares on September 10, 2026, generating gross proceeds of $4,107,222.71
  • Exchange listing: The securities trade on NASDAQ:CME
  • Relationship to issuer: Duffy's relationship to the issuer is listed as "Self" in the filing

Duffy's Proposed November 2026 Share Sale at CME Group

According to the Form 144 filing, Terrence Duffy, the named seller, intends to sell 27,000 shares of CME Group common stock, the issuer of which is CME Group, headquartered at 20 S Wacker Dr, Chicago, Illinois. CME Group operates one of the world's largest derivatives marketplace businesses, offering trading in futures and options across multiple asset classes. The aggregate market value of the proposed sale is listed as $8,338,917.93, and the approximate date of sale is stated as November 18, 2026.

The filing discloses that the 27,000 shares to be sold were acquired on March 15, 2025, through an executive compensation grant, with the nature of payment also described as an executive compensation grant. The notice was signed by Ayriana Trocki, and the date of notice is recorded as November 18, 2026. The filing further states that the person signing represents that no material adverse information regarding the issuer's current and prospective operations has been withheld from public disclosure.

The filing also reports that, within the past three months, Duffy sold 15,000 shares of CME Group common stock on September 10, 2026, with gross proceeds of $4,107,222.71. That prior transaction is disclosed in the "Securities Sold During The Past 3 Months" section of the form, as required under Rule 144 aggregation provisions. The combined proposed and recently completed sales total 42,000 shares across the two disclosed transactions.

What Was Disclosed

The Form 144 filing by Terrence Duffy covers a proposed sale of 27,000 CME Group common shares valued at $8,338,917.93, acquired via an executive compensation grant on March 15, 2025, with the sale to be conducted through Merrill and listed on the Nasdaq exchange.